Top Abstract Purchase Related
Home
>
Node
>
Subnode

Tactics of Selection of Anticoagulant Therapy in Patients With Atrial Fibrillation and Ischemic Heart Disease

Belenkov, Y.N.; SHakaryants, G.A.; Khabarova, N.V.

Kardiologiia 2018(3): 43-52

2018

ISSN/ISBN: 0022-9040
PMID: 29782270
Document Number: 697619
In the clinical practice a physician quite often is at a loss due to "freedom of choice" granted by availability of direct oral anticoagulants (DOAC). If a patient with nonvalvular atrial fibrillation (AF) has indications for therapy with anticoagulants which DOAC should be preferred? What are benefits for a patient with ischemic heart disease and AF when definite NOAC is chosen and what are risks inherent of this choice? Answers to such questions are given in this paper.

Document emailed within 1 workday
Secure & encrypted payments

Kotel'nikova, E.V.; Gridnev, V.I.; Dobgalevskiĭ, P.Ia.; Bespiatov, A.B. 2004: Prognostication of coronary atherosclerosis for selection of tactics of management of patients with ischemic heart disease Kardiologiia 44(3): 15-19
Olesin, A.I.; Shabrov, A.V.; Razumova, T.V.; Sinenko, V.I.; Aleksandrov, V.S. 2001: Sinus node functions, sinoatrial conduction, atrial conductivity after incipient paroxysms of atrial fibrillation and flutter in patients with ischemic heart disease Terapevticheskii Arkhiv 73(12): 40-44
Palareti, G. 1996: Anticoagulant therapy in patients with atrial fibrillation: the experience of the Centers of Surveillance. Study group of the "Italian Study on Complications of Oral Anticoagulant Therapy" (ISCOAT) Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 11(Suppl 2): 18s-20s
Guliamov, K.G. 1974: Effect of anticoagulant therapy on vascular permeability in patients with ischemic heart disease Terapevticheskii Arkhiv 46(9): 75-80
Cherniavskiĭ, A.M.; Kareva, I.E.; Pak, I.A.; Rakhmonov, S.S.; Romanov, A.B.; Pokushalov, E.A. 2013: The use of implantable devices for long-term monitoring of cardiac rhythm after surgical treatment of atrial fibrillation in patients with ischemic heart disease Kardiologiia 53(8): 60-66
Vakhliev, V.D.; Bogatyrev, I.V.; Uchaĭkina, L.V.; Syrkin, A.L. 1988: Effects of isoptin and obsidan on the coronary blood flow and tactics in anti-angina therapy of patients with ischemic heart disease Kardiologiia 28(10): 36-39
Frantz, E. 2000: What anticoagulant therapy should be used for what form of atrial fibrillation? Deutsche Medizinische Wochenschrift 125(Suppl 1): S10-S11
Kaem, G.R. 1975: Importance of long-term anticoagulant therapy in ischemic heart disease Terapevticheskii Arkhiv 47(10): 124-131
Lechat, P.; Lardoux, H.; Mallet, A.; Sanchez, P.; Derumeaux, G.; Lecompte, T.; Maillard, L.; Mas, J.L.; Mentré, F.; Pousset, F.; Lacomblez, L.; Pisica, G.; Solbes-Latourette, S.; Raynaud, P.; Chaumet-Riffaud, P. 2000: Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. a randomized trial (FFAACS) Therapie 55(6): 681-689
Lodder, J. 1989: Chronic anticoagulant treatment of patients with non-rheumatic atrial fibrillation Nederlands Tijdschrift Voor Geneeskunde 133(12): 602-603
Villani, M.; Iannucci, G.; Cangelosi, A.P.; Di Paolo, F.M.; Ciardo, R.; Baciarello, G. 1992: Paroxysmal atrial fibrillation in patients with chronic ischemic cardiopathy: a study of high-resolution atrial activation Giornale Italiano di Cardiologia 22(6): 715-722
Li, D.-q.; Feng, Y.-b.; Zhang, H.-q. 2004: The relationship between gap junctional remodeling and atrial fibrillation in patients with rheumatic heart disease Zhonghua Yi Xue Za Zhi 84(5): 384-386
Islam, M.S.; Islam, M.A.; Azad, A.K.; Banerjee, S.K.; Ahmed, C.M.; Haque, H.; Ahmed, M.K.; Rumki, R.S.; Mahmood, M.; Rashid, F.B. 2016: Use of Anticoagulant Warfarin in Patients Presenting with Atrial Fibrillation in a Tertiary Level Hospital Mymensingh Medical Journal: Mmj 25(3): 523-529
Ostroumova, O.D.; Cherniaeva, M.S.; Golovina, O.V. 2018: Atrial fibrillation as Risk Factor for Development of Cognitive Function Impairment and Dementia. Potential of Anticoagulant Therapy in Their Prevention Kardiologiia 58(9): 76-88
Rabotnikov, V.S.; Iakovlev, V.B.; Nesterenko, I.B.; Chernov, S.A.; Stepuro, D.K. 1993: The selection of patients in a therapeutic hospital for the surgical treatment of ischemic heart disease Voenno-Meditsinskii Zhurnal 1993(6): 26-29
Setiabudi, E.; Alwi, I.; Setiati, S. 2008: Oral anticoagulant treatment in management of elderly patients with atrial fibrillation [corrected]: is it beneficial or detrimental? Acta Medica Indonesiana 40(1): 40-47
Korkushko, O.V.; Butenko, A.G. 1983: Use of obzidan in continuous cardiac fibrillation and extrasystole in middle-aged and elderly patients with ischemic heart disease Klinicheskaia Meditsina 61(11): 34-40
Dumchius, A.S.; Navitskas, R.S.; Vaĭtsekavichius, E.Iu.; Valanchiute, A.L. 1985: Elaboration of criteria for selection of patients with chronic ischemic heart disease for direct myocardial revascularization surgery Kardiologiia 25(9): 21-24
Murashko, N.K.; Shkliaieva, O.P. 2013: Neurological characteristics of the ischemic stroke course in patients with atrial fibrillation Likars'ka Sprava 1: 77-82
Wang, J-zhi.; Du, R-ying.; Ding, H-xia.; Bai, B-Jian.; Wang, G.; Cui, G-fang.; Zhong, Z-huan. 2004: Limited posterior left atrial linear radiofrequency ablation for patients with chronic atrial fibrillation undergoing rheumatic valvular heart surgery Chinese Medical Journal 117(5): 758-760